Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
64
CYD Quote, Financials, Valuation and Earnings
Last price:
$53.44
Seasonality move
:
12.2%
Day range:
$51.00 - $54.22
52-week range:
$11.34 - $55.00
Dividend yield:
1.7%
P/E ratio:
21.61x
P/S ratio:
0.66x
P/B ratio:
1.61x
Volume:
113.1K
Avg. volume:
174.6K
1-year change:
378.23%
Market cap:
$2B
Revenue:
$2.7B
EPS (TTM):
$1.65
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $3.3B | $2.4B | $2.5B | $2.7B | |
| Revenue Growth (YoY) | 14.34% | 10.58% | -27.8% | 6.99% | 4.38% | |
| Cost of Revenues | $2.5B | $2.8B | $2B | $2.1B | $2.3B | |
| Gross Profit | $462.2M | $457.7M | $390.7M | $411.5M | $391.6M | |
| Gross Profit Margin | 15.5% | 13.88% | 16.41% | 16.16% | 14.73% | |
| R&D Expenses | $90.8M | $131.6M | $124.2M | $123.7M | $136.8M | |
| Selling, General & Admin | $255M | $272.3M | $239.3M | $264.2M | $251.9M | |
| Other Inc / (Exp) | -$8.2M | -$11.8M | -$2.5M | $20.7M | $13.3M | |
| Operating Expenses | $315.5M | $402.5M | $362.8M | $387.9M | $388.7M | |
| Operating Income | $146.7M | $55.2M | $27.8M | $23.6M | $3M | |
| Net Interest Expenses | -- | $18M | $14.2M | $14.1M | $10.8M | |
| EBT. Incl. Unusual Items | $140.8M | $84.9M | $62.9M | $71.9M | $72.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27.9M | $6.8M | $8.8M | $21M | $17.9M | |
| Net Income to Company | $140.8M | $70M | $58.6M | $80.6M | $86.2M | |
| Minority Interest in Earnings | -$33.4M | $21M | $17.4M | $19.4M | $23.4M | |
| Net Income to Common Excl Extra Items | $79.5M | $63.2M | $49.8M | $59.7M | $68.3M | |
| Basic EPS (Cont. Ops) | $1.95 | $1.03 | $0.79 | $0.99 | $1.14 | |
| Diluted EPS (Cont. Ops) | $1.95 | $1.03 | $0.79 | $0.99 | $1.14 | |
| Weighted Average Basic Share | $40.9M | $40.9M | $40.9M | $40.9M | $39.3M | |
| Weighted Average Diluted Share | $40.9M | $40.9M | $40.9M | $40.9M | $39.3M | |
| EBITDA | $233.8M | $144.2M | $120.6M | $117.4M | $102.2M | |
| EBIT | $162.2M | $55.2M | $27.8M | $23.6M | $3M | |
| Revenue (Reported) | $3B | $3.3B | $2.4B | $2.5B | $2.7B | |
| Operating Income (Reported) | $146.7M | $55.2M | $27.8M | $23.6M | $3M | |
| Operating Income (Adjusted) | $162.2M | $55.2M | $27.8M | $23.6M | $3M | |
| Period Ending | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2020-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $560.6M | $593.7M | $660.1M | $712.6M | $923.6M | |
| Revenue Growth (YoY) | -15.59% | 5.9% | 11.18% | 7.96% | 29.61% | |
| Cost of Revenues | $451.9M | $488.1M | $539.4M | $608.1M | $789.9M | |
| Gross Profit | $108.7M | $105.5M | $120.7M | $104.5M | $133.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $21.4M | $16.5M | $24.6M | $16.2M | $19.3M | |
| Selling, General & Admin | $52.6M | $60.5M | $58.4M | $59.9M | $59.8M | |
| Other Inc / (Exp) | $36.4K | $446.4K | $132K | $508.9K | $144.6K | |
| Operating Expenses | $71.5M | $69.9M | $77.6M | $61.7M | $70.4M | |
| Operating Income | $37.2M | $35.7M | $43.1M | $42.8M | $63.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $34M | $33.7M | $38.6M | $38.6M | $59.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.8M | $6.8M | $7.7M | $7.9M | $11.6M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$8.3M | -$7.4M | -$10.1M | -$9.2M | -$13.5M | |
| Net Income to Common Excl Extra Items | $18.9M | $19.5M | $20.7M | $21.5M | $34.5M | |
| Basic EPS (Cont. Ops) | $0.48 | $0.48 | $0.51 | $0.53 | $0.84 | |
| Diluted EPS (Cont. Ops) | $0.48 | $0.48 | $0.51 | $0.53 | $0.84 | |
| Weighted Average Basic Share | $39.3M | $40.7M | $40.9M | $40.8M | $40.8M | |
| Weighted Average Diluted Share | $39.3M | $40.7M | $40.9M | $40.8M | $40.8M | |
| EBITDA | $37.2M | $36.1M | $43.2M | $43.3M | $63.4M | |
| EBIT | $37.2M | $36.1M | $43.2M | $43.3M | $63.4M | |
| Revenue (Reported) | $560.6M | $593.7M | $660.1M | $712.6M | $923.6M | |
| Operating Income (Reported) | $37.2M | $35.7M | $43.1M | $42.8M | $63.3M | |
| Operating Income (Adjusted) | $37.2M | $36.1M | $43.2M | $43.3M | $63.4M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.6B | $2.7B | $2.4B | $2.7B | $3.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $2.2B | $2B | $2.2B | $2.7B | |
| Gross Profit | -- | $416.5M | $405.8M | $437.9M | $449.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $145.9M | $119.9M | $119.6M | $148.1M | |
| Selling, General & Admin | -- | $245.6M | $252.5M | $293.6M | $279.9M | |
| Other Inc / (Exp) | $1.9M | -$18.5M | $6.3M | $22.2M | $15.8M | |
| Operating Expenses | -- | $391.6M | $372.4M | $413.2M | $427.9M | |
| Operating Income | -- | $24.9M | $33.4M | $24.8M | $21.5M | |
| Net Interest Expenses | $10.6M | $15.9M | $13.5M | $12.1M | $9.6M | |
| EBT. Incl. Unusual Items | -- | $54M | $75.5M | $79.1M | $98.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $2.1M | $16.3M | $19.4M | $19.7M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$16.1M | $12.8M | $20.1M | $22M | $33.4M | |
| Net Income to Common Excl Extra Items | -- | $30.3M | $63.8M | $70.1M | $95.3M | |
| Basic EPS (Cont. Ops) | -- | $0.43 | $1.07 | $1.18 | $1.64 | |
| Diluted EPS (Cont. Ops) | -- | $0.43 | $1.07 | $1.18 | $1.64 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | $46.9M | $91.7M | $101.4M | $124.3M | |
| EBIT | -- | $24.9M | $33.4M | $24.8M | $21.5M | |
| Revenue (Reported) | $3.6B | $2.7B | $2.4B | $2.7B | $3.1B | |
| Operating Income (Reported) | -- | $24.9M | $33.4M | $24.8M | $21.5M | |
| Operating Income (Adjusted) | -- | $24.9M | $33.4M | $24.8M | $21.5M | |
| Period Ending | 2022-02-14 | 2023-02-14 | 2024-02-14 | 2025-02-14 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $899.6M | $819.4M | $694.9M | $851.6M | $881.4M | |
| Short Term Investments | $40.6M | $56.2M | -- | -- | -- | |
| Accounts Receivable, Net | $45.9M | $1.1B | $977.2M | $1.1B | $1.2B | |
| Inventory | $687M | $819.8M | $712.7M | $668.8M | $661M | |
| Prepaid Expenses | $10.3M | $10.4M | $11.8M | $10.9M | $21M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $2.9B | $2.8B | $2.5B | $2.7B | $2.8B | |
| Property Plant And Equipment | $710.6M | $712.8M | $624M | $543.1M | $509.7M | |
| Long-Term Investments | $56.6M | $24.9M | $23M | $34.1M | $47M | |
| Goodwill | $32.5M | $33.4M | $30.8M | $30M | $29.1M | |
| Other Intangibles | $194.6M | $242.5M | $240.9M | $245.3M | $234.3M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4B | $3.9B | $3.5B | $3.6B | $3.7B | |
| Accounts Payable | $557.9M | $1.2B | $995.4M | $1.1B | $1.2B | |
| Accrued Expenses | $145.1M | $134.4M | $84.3M | $102.4M | $117.6M | |
| Current Portion Of Long-Term Debt | $264.8M | $329.9M | $310.4M | $261M | $256.4M | |
| Current Portion Of Capital Lease Obligations | $3.5M | $4.3M | $4.6M | $4.7M | $4.5M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2B | $2B | $1.6B | $1.7B | $1.8B | |
| Long-Term Debt | $76.5M | $17.8M | $32.8M | $99.5M | $91.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.2B | $2B | $1.7B | $1.9B | $2B | |
| Common Stock | $318.5M | $326.5M | $299.4M | $293.4M | $285.1M | |
| Other Common Equity Adj | $51.7M | $53.3M | $48.1M | $51.3M | $58.3M | |
| Common Equity | $1.4B | $1.4B | $1.3B | $1.3B | $1.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $431.3M | $432.5M | $406.5M | $415.8M | $429.5M | |
| Total Equity | $1.8B | $1.8B | $1.7B | $1.7B | $1.7B | |
| Total Liabilities and Equity | $4B | $3.8B | $3.4B | $3.6B | $3.6B | |
| Cash and Short Terms | $940.2M | $819.4M | $694.9M | $851.6M | $881.4M | |
| Total Debt | $341.3M | $17.8M | $32.8M | $104.2M | $96.1M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $875.9M | $784.6M | $774.2M | $872.7M | $1.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.6B | $984M | $1.2B | $1.4B | $1.8B | |
| Inventory | $590M | $602.7M | $679.8M | $627.8M | $654.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.1B | $2.4B | $2.7B | $2.9B | $3.5B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Accounts Payable | $1.3B | $906.2M | $1.1B | $1.2B | $1.7B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.3B | $906.2M | $1.1B | $1.2B | $1.7B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Liabilities and Equity | -- | -- | -- | -- | -- | |
| Cash and Short Terms | $875.9M | $784.6M | $774.2M | $872.7M | $1.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $140.8M | $70M | $58.6M | $80.6M | $86.2M | |
| Depreciation & Amoritzation | $71.7M | $88.9M | $92.8M | $93.8M | $99.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | $1.1M | |
| Change in Accounts Receivable | -$34.6M | $201.6M | -$1.1M | -$135.5M | -$173.8M | |
| Change in Inventories | -$244.6M | -$114.9M | $27.6M | $31.3M | -$9.4M | |
| Cash From Operations | $205.1M | $79.7M | -$12.4M | $181.8M | $117.2M | |
| Capital Expenditures | $157.2M | $133.3M | $88.7M | $57.5M | $75.8M | |
| Cash Acquisitions | -- | -- | -- | -- | $104.2K | |
| Cash From Investing | -$113.9M | -$134M | -$31.3M | -$35.5M | $7.8M | |
| Dividends Paid (Ex Special Dividend) | -$35.6M | $69.6M | $16.3M | $11.3M | $14.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $323.1M | $300.3M | $305M | $458.1M | $281.8M | |
| Long-Term Debt Repaid | -$303.1M | -$308.1M | -$288M | -$435.8M | -$291.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | $39.7M | |
| Other Financing Activities | -$29.8M | -$34.7M | -$7.3M | -$2.1M | $867.6K | |
| Cash From Financing | -$66.9M | -$112.1M | -$14.6M | $6M | -$74.2M | |
| Beginning Cash (CF) | $833.7M | $763.2M | $644.3M | $785.7M | $827M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $24.3M | -$168.9M | -$50M | $154.3M | $51.6M | |
| Ending Cash (CF) | $851.7M | $591.7M | $602.7M | $941.9M | $879.4M | |
| Levered Free Cash Flow | $47.9M | -$53.6M | -$101.1M | $124.3M | $41.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-02-14 | 2023-02-14 | 2024-02-14 | 2025-02-14 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Related Companies
Get CYD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CYD
Sector
P/E ratio
21.61x
20.17x
PEG ratio
0.61x
0.18x
P/B ratio
1.61x
1.80x
Price / LTM sales
0.66x
0.87x
Growth Metrics
CYD
Sector
Revenue growth
--
4.5%
Earnings growth
--
2.91%
Revenue (5-year growth)
0.39%
4.63%
Earnings forecast
--
$0.33
Profitability
CYD
Sector
Profitability FY 2024
$391.6M
$234.7M
Return on invested capital
4.01%
4.57%
Return on assets
--
3.16%
Return on equity
--
8.11%
Earnings Date
Last Earnings Date
Aug
8
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Nov
7
Balance Sheet
CYD
Sector
Total cash
$1.1B
$137.1M
Short term investments
--
$31.1M
Total assets
$3.7B
$1.4B
Long term debt
--
$44.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
